Technology | Computed Tomography (CT) | September 09, 2015

FDA Clears Philips Spectral CT Diagnostic Suite

On-demand visualization and analytics solution for Philips IQon Spectral CT delivers expanded clinical application

Spectral CT,  Philips

Radiologists using the Philips spectral CT software to view a spectral CT image reconstruction at various energy levels.

September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral Diagnostic Suite (SpDS), which offers a set of advanced visualization and analysis tools designed for the IQon Spectral computed tomography (CT) technology. The software offers enhanced spectral viewing and clinical applications capabilities.

CT imaging is widely used in the diagnosis of many different diseases and injuries. By providing spectral capabilities within traditional CT applications, SpDS offers a new level of flexibility for CT users. It allows clinicians to utilize the spectral information on-demand, without the added complexity of special modes or workstations that disrupt user workflow. Additionally, because there is no need to bring the patient back for additional imaging, on-demand spectral analysis of a particular region allows the physician to further analyze incidental findings.   
"Philips Spectral suite offers a new level of control for clinicians, allowing for segmentation on different energy levels, more detailed comparison between images, and advanced fusion capabilities, for diagnostic confidence,” said Prabhakar Rajiah, MBBS, M.D., FRCR, assistant professor of radiology, University Hospitals of Cleveland, UH Case Medical Center, Department of Radiology, who collaborated with Philips on the development of the suite. 

The Philips SpDS package includes:
·      Spectral enhanced Comprehensive Cardiac Analysis (sCCA)
·      Spectral enhanced Advanced Vessel Analysis (sAVA)
·      Spectral enhanced Tumor Tracking (sTT).
 
The Philips SpDS also allows for viewing and analysis of spectral datasets in a variety of settings: a reading room, on picture archiving and communication systems (PACS), or from remote locations.

Spectral CT imaging allows viewing of the same anatomy at two different kV energies. Different anatomical features are enhanced and easier to see at different energy levels. Additionally, the spectral software can highlight or eliminate specific chemical compounds based on their atomic number, including iodine, calcium, etc. This allows differentiation between calcified coronary lesions and iodine contrast in the blood vessel, or enables contrast and non-contrast images from the same scan.
 
For more information: www.spectralctlearningcenter.philips.com

Related Content

This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT)...
Canon Medical Systems' Aquilion Precision CT Receives FDA Clearance
Technology | Computed Tomography (CT) | April 13, 2018
April 13, 2018 — Canon Medical Systems USA Inc. this week received U.S.
Brainomix Secures $9.8m Investment to Tackle Strokes With AI
News | Stroke | April 05, 2018
April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its...
FDA Clears Siemens Somatom Edge Plus CT System
Technology | Computed Tomography (CT) | April 04, 2018
April 4, 2018 — The U.S.
Radiologist Uses Virtual Reality as Interventional Radiology Teaching Tool

Ziv Haskal, M.D., of the University of Virginia Health System, steps into virtual reality. Image courtesy of Josh Barney, UVA Health System

News | Interventional Radiology | March 27, 2018
Physicians, trainees and even laypeople can now stand right beside an expert radiologist as he performs one of the most...
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
Materialise First Company to Receive FDA Clearance for Diagnostic 3-D-Printed Anatomical Models
Technology | Medical 3-D Printing | March 23, 2018
March 23, 2018 — Materialise NV became the first company in the world to receive U.S.
Overlay Init